Serum C-reactive Protein and Its Relationship with Clinic Factors in Patients with Polycystic Ovary Syndrome

胡卫红,乔杰,王丽娜,张小为,李美芝
DOI: https://doi.org/10.3969/j.issn.1672-1861.2007.01.013
2007-01-01
Abstract:Objective To measure serum C-reactive protein (CRP) levels and analyze its associations with clinical factors in patients with polycystic ovary syndrome (PCOS).Methods Ninety PCOS women and 20 ovulating healthy women with body mass index (BMI) 25 kg/m2 as controls were recruited. PCOS women were divided to two groups: 48 BMI≥25 kg/m2 patients as obese group; 42 BMI25 kg/m2 as non-obese group. Serum CRP was assayed by immunoturbidimetry. And triglycerides (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C)and low density lipoprotein cholesterol (LDL-C) were measured. Oral glucose tolerance test (OGTT) and insulin sensitivity were also assessed in PCOS patients.Results ① Obese and non-obese PCOS group presented markedly higher logCRP than controls group (both P0.05), and the logCRP is higher in the obese PCOS group than non-obese PCOS group (P0.05). ② Univariate analysis revealed that logCRP was significantly and positively correlation with BMI and HOMA-IR(P0.05); LogCRP was significantly and negatively correlation with HDL-C and ISI(P0.05)in patients with PCOS. Partial correlation showed that logCRP was correlation with HOMA-IR(P0.05), and logCRP was significantly and negatively correlation with ISI(P0.05)in patients with PCOS. Conclusions Chronic inflammation maybe exists in patients with PCOS. CRP may be a predictor of future type 2 diabetes mellitus in PCOS patients.
What problem does this paper attempt to address?